Literature DB >> 12410395

Inverse association of Pin1 and tau accumulation in Alzheimer's disease hippocampus.

Max Holzer1, Ulrich Gärtner, Andrea Stöbe, Wolfgang Härtig, Hildegard Gruschka, Martina K Brückner, Thomas Arendt.   

Abstract

Neurofibrillary degeneration, one of the pathological hallmarks of Alzheimer's disease, is not ubiquitous to all brain regions or neurons. While a high degree of vulnerability has been documented for entorhinal cortex, hippocampal and neocortical pyramidal neurons other brain structures are largely spared. Even within highly vulnerable regions such as hippocampus neurons are affected to a variable extent. The molecular basis for this selective susceptibility remains unknown. Neurofibrillary degeneration involves hyperphosphorylation of tau which critically impairs its binding capacity to microtubule and, therefore, is believed to disrupt the axonal cytoskeleton. Recently, Lu et al. [Nature (1999) 399:784] described the ability of the peptidyl-prolyl cis-trans isomerase Pin1 to recover microtubule-binding affinity and microtubule stabilisation of phosphorylated tau. In the present study, we analysed the potential involvement of Pin1 in selective vulnerability of hippocampal neurons to neurofibrillary degeneration in Alzheimer's disease. Pin1 immunoreactivity appeared as cytoplasmic granules affecting hippocampal subfields to a different extent (CA2>subiculum>CA1>CA3/CA4). Since the main markers of granulovacuolar degeneration do not co-label Pin1-immunoreactive granules, we propose that these granules may represent a new lesion in Alzheimer's disease. Neurons containing Pin1 granules were devoid of neurofibrillary tangles. Granular accumulation of Pin1 may correspond to an absence of neurofibrillary lesions in these cells and might be associated with other mechanisms of neuronal degeneration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12410395     DOI: 10.1007/s00401-002-0581-1

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  20 in total

1.  Pin1 levels are downregulated during ER stress in human neuroblastoma cells.

Authors:  Yolanda S Kap; Jeroen J M Hoozemans; Adee J Bodewes; Rob Zwart; Onno C Meijer; Frank Baas; Wiep Scheper
Journal:  Neurogenetics       Date:  2006-09-14       Impact factor: 2.660

Review 2.  The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease.

Authors:  Yanuar Alan Sulistio; Klaus Heese
Journal:  Mol Neurobiol       Date:  2015-01-07       Impact factor: 5.590

Review 3.  Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.

Authors:  D Allan Butterfield; Marzia Perluigi; Tanea Reed; Tasneem Muharib; Christopher P Hughes; Renã A S Robinson; Rukhsana Sultana
Journal:  Antioxid Redox Signal       Date:  2012-01-18       Impact factor: 8.401

Review 4.  Topographic regulation of neuronal intermediate filaments by phosphorylation, role of peptidyl-prolyl isomerase 1: significance in neurodegeneration.

Authors:  B K Binukumar; Varsha Shukla; Niranjana D Amin; Preethi Reddy; Suzanne Skuntz; Philip Grant; Harish C Pant
Journal:  Histochem Cell Biol       Date:  2013-06-23       Impact factor: 4.304

5.  Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease.

Authors:  W Michael Caudle; Sheng Pan; Min Shi; Thomas Quinn; Jake Hoekstra; Richard P Beyer; Thomas J Montine; Jing Zhang
Journal:  Proteomics Clin Appl       Date:  2008-09-10       Impact factor: 3.494

6.  Regional expression of key cell cycle proteins in brain from subjects with amnestic mild cognitive impairment.

Authors:  Rukhsana Sultana; D Allan Butterfield
Journal:  Neurochem Res       Date:  2006-09-28       Impact factor: 3.996

7.  Granular expression of prolyl-peptidyl isomerase PIN1 is a constant and specific feature of Alzheimer's disease pathology and is independent of tau, Aβ and TDP-43 pathology.

Authors:  Ayoub Dakson; Osamu Yokota; Margaret Esiri; Eileen H Bigio; Michael Horan; Neil Pendleton; Anna Richardson; David Neary; Julie S Snowden; Andrew Robinson; Yvonne S Davidson; David M A Mann
Journal:  Acta Neuropathol       Date:  2011-01-18       Impact factor: 17.088

8.  Granulovacuolar degeneration (GVD) bodies of Alzheimer's disease (AD) resemble late-stage autophagic organelles.

Authors:  K E Funk; R E Mrak; J Kuret
Journal:  Neuropathol Appl Neurobiol       Date:  2011-04       Impact factor: 8.090

Review 9.  Brain hypometabolism triggers PHF-like phosphorylation of tau, a major hallmark of Alzheimer's disease pathology.

Authors:  Thomas Arendt; Jens Stieler; Max Holzer
Journal:  J Neural Transm (Vienna)       Date:  2014-12-06       Impact factor: 3.575

Review 10.  Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.

Authors:  Rukhsana Sultana; Marzia Perluigi; D Allan Butterfield
Journal:  Acta Neuropathol       Date:  2009-03-14       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.